131 related articles for article (PubMed ID: 28433113)
1. Wilson disease: brain pathology.
Poujois A; Mikol J; Woimant F
Handb Clin Neurol; 2017; 142():77-89. PubMed ID: 28433113
[TBL] [Abstract][Full Text] [Related]
2. Copper deposition in oligodendroglial cells in an autopsied case of hepatolenticular degeneration.
Nishimuta M; Masui K; Yamamoto T; Ikarashi Y; Tokushige K; Hashimoto E; Nagashima Y; Shibata N
Neuropathology; 2018 Jun; 38(3):321-328. PubMed ID: 29468756
[TBL] [Abstract][Full Text] [Related]
3. Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study.
Dusek P; Bahn E; Litwin T; Jabłonka-Salach K; Łuciuk A; Huelnhagen T; Madai VI; Dieringer MA; Bulska E; Knauth M; Niendorf T; Sobesky J; Paul F; Schneider SA; Czlonkowska A; Brück W; Wegner C; Wuerfel J
Neuropathol Appl Neurobiol; 2017 Oct; 43(6):514-532. PubMed ID: 27543917
[TBL] [Abstract][Full Text] [Related]
4. [Difference in imaging and metal metabolism between hepatic and cerebral type Wilson disease].
Zhou XX; Li XH; Pu XY; Qin HL; Li XB; Chu JP; Yang ZY; Huang HW; Liang XL
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):176-181. PubMed ID: 28162166
[No Abstract] [Full Text] [Related]
5. Wilson disease.
Kitzberger R; Madl C; Ferenci P
Metab Brain Dis; 2005 Dec; 20(4):295-302. PubMed ID: 16382340
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
[No Abstract] [Full Text] [Related]
7. Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease.
Walter U; Krolikowski K; Tarnacka B; Benecke R; Czlonkowska A; Dressler D
Neurology; 2005 May; 64(10):1726-32. PubMed ID: 15911799
[TBL] [Abstract][Full Text] [Related]
8. Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging.
Su D; Zhang Z; Zhang Z; Zheng S; Yao T; Dong Y; Zhu W; Wei N; Suo Y; Liu X; Zhao H; Wang Z; Ma H; Li W; Zhou J; Lam JST; Wu T; Dusek P; Stoessl AJ; Wang X; Jing J; Feng T
Neurology; 2024 Jun; 102(12):e209478. PubMed ID: 38830145
[TBL] [Abstract][Full Text] [Related]
9. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
[TBL] [Abstract][Full Text] [Related]
10. MR Imaging of the Brain in Neurologic Wilson Disease.
Yu XE; Gao S; Yang RM; Han YZ
AJNR Am J Neuroradiol; 2019 Jan; 40(1):178-183. PubMed ID: 30635331
[TBL] [Abstract][Full Text] [Related]
11. [Pathological status of catecholamines in the corpus striatum in hepatocerebral dystrophy (Wilson-Konovalov disease)].
Barkhatova VP; Larskiĭ EG; Ivanova-Smolenskaia IA; Markova ED; Demina EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(4):8-10. PubMed ID: 1333712
[TBL] [Abstract][Full Text] [Related]
12. Wilson's disease with extensive degeneration of cerebral white matter and cortex.
Shimoji A; Miyakawa T; Watanabe K; Yamashita K; Katsuragi S; Kabashima K
Jpn J Psychiatry Neurol; 1987 Dec; 41(4):709-17. PubMed ID: 3453418
[TBL] [Abstract][Full Text] [Related]
13. Neurologic impairment in Wilson disease.
Dusek P; Litwin T; Członkowska A
Ann Transl Med; 2019 Apr; 7(Suppl 2):S64. PubMed ID: 31179301
[TBL] [Abstract][Full Text] [Related]
14. Extensive cortico-subcortical lesions in Wilson's disease: clinico-pathological study of two cases.
Mikol J; Vital C; Wassef M; Chappuis P; Poupon J; Lecharpentier M; Woimant F
Acta Neuropathol; 2005 Nov; 110(5):451-8. PubMed ID: 16195917
[TBL] [Abstract][Full Text] [Related]
15. Brain metal accumulation in Wilson's disease.
Litwin T; Gromadzka G; Szpak GM; Jabłonka-Salach K; Bulska E; Członkowska A
J Neurol Sci; 2013 Jun; 329(1-2):55-8. PubMed ID: 23597670
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of oxidative events and copper accumulatıon in oral tissues of patients wıth Wilson's disease: three case report.
Ozturk M; Karacelebi E; Gungor K; Coskun S; Boysan E
Int J Clin Exp Pathol; 2015; 8(4):3943-5. PubMed ID: 26097579
[TBL] [Abstract][Full Text] [Related]
17. Seven-tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation.
Fritzsch D; Reiss-Zimmermann M; Trampel R; Turner R; Hoffmann KT; Schäfer A
Invest Radiol; 2014 May; 49(5):299-306. PubMed ID: 24220252
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y
PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414
[TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.
Stättermayer AF; Traussnigg S; Dienes HP; Aigner E; Stauber R; Lackner K; Hofer H; Stift J; Wrba F; Stadlmayr A; Datz C; Strasser M; Maieron A; Trauner M; Ferenci P
J Hepatol; 2015 Jul; 63(1):156-63. PubMed ID: 25678388
[TBL] [Abstract][Full Text] [Related]
20. Study on Lesion Assessment of Cerebello-Thalamo-Cortical Network in Wilson's Disease with Diffusion Tensor Imaging.
Wang A; Wu H; Xu C; Tang L; Lee J; Wang M; Jiang M; Li C; Lu Q; Zhang C
Neural Plast; 2017; 2017():7323121. PubMed ID: 28781902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
